| 10021 |
Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis |
Department of Pharmacology |
2010 |
| 10022 |
Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis |
Department of Pharmacology |
2010 |
| 10023 |
Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis |
Department of Microbiology and Immunology |
2010 |
| 10024 |
Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis |
Department of Pharmacology |
2010 |
| 10025 |
Influence of dipyridamole and its combinationr on adjuvant arthritis |
|
2010 |
| 10026 |
Interaction between serum prohepcidin, anemia and chronic hepatitis in hemodialyzed patients |
Internal Medicine |
2010 |
| 10027 |
Interaction between serum prohepcidin, anemia and chronic hepatitis in hemodialyzed patients |
Department of Clinical Pathology |
2010 |
| 10028 |
Interaction between serum prohepcidin, anemia and chronic hepatitis in hemodialyzed patients |
Internal Medicine |
2010 |
| 10029 |
Interaction between serum prohepcidin, anemia and chronic hepatitis in hemodialyzed patients |
Department of Clinical Pathology |
2010 |
| 10030 |
Interaction between serum prohepcidin, anemia and chronic hepatitis in hemodialyzed patients |
Department of Clinical Pathology |
2010 |